Oppenheimer Maintains Outperform on Humana, Raises Price Target to $400
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Michael Wiederhorn maintains an Outperform rating on Humana (NYSE:HUM) and raises the price target from $370 to $400.
August 01, 2024 | 12:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oppenheimer analyst Michael Wiederhorn maintains an Outperform rating on Humana and raises the price target from $370 to $400.
The raised price target and maintained Outperform rating from a reputable analyst at Oppenheimer is likely to positively influence investor sentiment and drive short-term price appreciation for Humana.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100